Reports
Reports
Sale
The global endometriosis treatment market size was estimated to be worth USD 1.55 billion in 2023. The market is expected to grow at a CAGR of 7.7% during the forecast period of 2024-2032 to attain a market value of USD 3.02 billion by 2032. The growth of the market is driven by the rising research and development activities.
Endometriosis is a medical condition in which the tissue lining the uterus grows outside the uterus, causing pain and discomfort. The condition is often associated with infertility, and it affects millions of women worldwide. The global endometriosis treatment market is highly competitive, with key players focusing on research and development activities to develop innovative products and strengthen their market position.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Endometriosis is a common medical condition that affects women of reproductive age. It is estimated that approximately 10% of women worldwide are affected by endometriosis. The condition occurs when the tissue lining the uterus (endometrium) grows outside the uterus, leading to pain and discomfort.
Endometriosis is often misdiagnosed or undiagnosed, which leads to delayed diagnosis and treatment. The exact cause of endometriosis is unknown, but it is believed to be a combination of genetic and environmental factors. It is also more common among women who have never had children. Endometriosis can affect various parts of the body, including the ovaries, fallopian tubes, and the tissue lining the pelvis. The most common symptoms of endometriosis include pelvic pain, painful periods, pain during intercourse, and infertility.
The prevalence of endometriosis varies by region and age group. According to a systematic review and meta-analysis published in The Lancet in 2020, the global prevalence of endometriosis was estimated to be 1.7% (95% CI 1.5-1.9) among women of reproductive age. The prevalence was found to be highest in North America (2.6%, 95% CI 2.2-3.0) and lowest in Africa (1.0%, 95% CI 0.5-1.5).
The same study also found that the prevalence of endometriosis increased with age, peaking in women in their 40s. It was also found to be more common among women with infertility, chronic pelvic pain, and dysmenorrhea (painful periods).
The market can be categorised into indication type, diagnostic method, treatment method, drug class, and distribution channel.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Breakup by Indication Type
Market Breakup by Diagnostic Method
Market Breakup by Treatment Method
Endometriosis Treatment Market Breakup by Drug Class
Market Breakup by Distribution Channel
Endometriosis Treatment Market Breakup by Region
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The global endometriosis treatment market is expected to witness significant growth during the forecast period of 2024-2032. The market is being driven by factors such as the increasing prevalence of endometriosis, growing awareness and diagnosis of the condition, and the availability of advanced treatments and therapies.
Hormonal therapy is the most commonly used treatment for endometriosis, followed by non-steroidal anti-inflammatory drugs (NSAIDs), gonadotropin-releasing hormone (GnRH) agonists, aromatase inhibitors, and progestins. Laparoscopy is the most common diagnostic method used to diagnose endometriosis.
North America dominates the endometriosis treatment market, followed by Europe and the Asia Pacific. The market in North America is driven by the high prevalence of endometriosis and the availability of advanced healthcare infrastructure. The market in Europe is also expected to grow significantly, with key players focusing on research and development activities to develop innovative products. The market in the Asia Pacific region is expected to grow at the highest CAGR during the forecast period, owing to the increasing awareness about endometriosis and the rising healthcare expenditure in the region.
The report gives an in-depth analysis of the key players involved in the Endometriosis Treatment market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Indication Type |
|
Breakup by Diagnostic Method |
|
Breakup by Treatment Method |
|
Breakup by Drug Class |
|
Breakup by Distribution Channel |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
2 Research Methodology
3 Executive Summary
4 Endometriosis Overview
4.1 Guidelines and Stages
4.2 Pathophysiology
4.3 Screening and Diagnosis
4.4 Treatment Pathway
5 Patient Profile
5.1 Patient Profile Overview
5.2 Patient Psychology and Emotional Impact Factors
5.3 Risk Assessment and Treatment Success Rate
6 Current Scenario Evaluation and Regulatory Framework
6.1 Emerging Therapies and Clinical Trials
6.2 Patent Landscape
6.2.1 Patent Overview
6.2.1.1 Patent Status and Expiry
6.2.1.2 Timelines from Drug Development to Commercial Launch
6.2.1.3 New Drug Application
6.2.1.3.1 Documentation and Approval Process
6.3 Cost of Treatment
6.4 Regulatory Framework
6.4.1 Regulatory Overview
6.4.1.1 US FDA
6.4.1.2 EU EMA
6.4.1.3 INDIA CDSCO
6.4.1.4 JAPAN PMDA
6.4.1.5 Others
7 Challenges and Unmet Needs
7.1 Treatment Pathway Challenges
7.2 Compliance and Drop-Out Analysis
7.3 Awareness and Prevention Gaps
8 Global Endometriosis Treatment Market
8.1 Global Endometriosis Treatment Market Overview
8.2 Global Endometriosis Treatment Market Analysis
8.2.1 Market Overview
8.2.1.1 Global Endometriosis Treatment Market Historical Value (2017-2023)
8.2.1.2 Global Endometriosis Treatment Market Forecast Value (2024-2032)
8.2.2 Global Endometriosis Treatment Market by Indication Type
8.2.2.1 Market Overview
8.2.2.1.1 Superficial Peritoneal Lesion
8.2.2.1.2 Endometrioma
8.2.2.1.3 Deeply Infiltrating Endometriosis
8.2.2.1.4 Others
8.2.3 Global Endometriosis Treatment Market by Diagnostic Method
8.2.3.1 Market Overview
8.2.3.1.1 Ultrasound
8.2.3.1.2 Pelvic Examination
8.2.3.1.3 Laparoscopy
8.2.3.1.4 Magnetic Resonance Imaging
8.2.3.1.5 Others
8.2.4 Global Endometriosis Treatment Market by Treatment Method
8.2.4.1 Market Overview
8.2.4.1.1 Hormonal Therapy
8.2.4.1.2 Pain Management
8.2.4.1.3 Others
8.2.5 Global Endometriosis Treatment Market by Drug Class
8.2.5.1.1 Oral Contraceptives
8.2.5.1.2 Progestins
8.2.5.1.3 NSAIDs
8.2.5.1.4 GnRH Analogues
8.2.5.1.5 Others
8.2.6 Global Endometriosis Treatment Market by Distribution Channel
8.2.6.1 Market Overview
8.2.6.1.1 Hospital Pharmacies
8.2.6.1.2 Retail Pharmacies
8.2.6.1.3 Online Pharmacies
8.2.7 Global Endometriosis Treatment Market by Region
8.2.7.1 Market Overview
8.2.7.1.1 North America
8.2.7.1.2 Europe
8.2.7.1.3 Asia Pacific
8.2.7.1.4 Latin America
8.2.7.1.5 Middle East and Africa
9 North America Endometriosis Treatment Market
9.1 Market Share by Country
9.2 United States of America
9.2.1 Historical Trend (2017-2023)
9.2.2 Forecast Trend (2024-2032)
9.3 Canada
9.3.1 Historical Trend (2017-2023)
9.3.2 Forecast Trend (2024-2032)
10 Europe Endometriosis Treatment Market
10.1 Market Share by Country
10.2 United Kingdom
10.2.1 Historical Trend (2017-2023)
10.2.2 Forecast Trend (2024-2032)
10.3 Germany
10.3.1 Historical Trend (2017-2023)
10.3.2 Forecast Trend (2024-2032)
10.4 France
10.4.1 Historical Trend (2017-2023)
10.4.2 Forecast Trend (2024-2032)
10.5 Italy
10.5.1 Historical Trend (2017-2023)
10.5.2 Forecast Trend (2024-2032)
10.6 Others
11 Asia Pacific Endometriosis Treatment Market
11.1 Market Share by Country
11.2 China
11.2.1 Historical Trend (2017-2023)
11.2.2 Forecast Trend (2024-2032)
11.3 Japan
11.3.1 Historical Trend (2017-2023)
11.3.2 Forecast Trend (2024-2032)
11.4 India
11.4.1 Historical Trend (2017-2023)
11.4.2 Forecast Trend (2024-2032)
11.5 ASEAN
11.5.1 Historical Trend (2017-2023)
11.5.2 Forecast Trend (2024-2032)
11.6 Australia
11.6.1 Historical Trend (2017-2023)
11.6.2 Forecast Trend (2024-2032)
11.7 Others
12 Latin America Endometriosis Treatment Market
12.1 Market Share by Country
12.2 Brazil
12.2.1 Historical Trend (2017-2023)
12.2.2 Forecast Trend (2024-2032)
12.3 Argentina
12.3.1 Historical Trend (2017-2023)
12.3.2 Forecast Trend (2024-2032)
12.4 Mexico
12.4.1 Historical Trend (2017-2023)
12.4.2 Forecast Trend (2024-2032)
12.5 Others
13 Middle East and Africa Endometriosis Treatment Market
13.1 Market Share by Country
13.2 Saudi Arabia
13.2.1 Historical Trend (2017-2023)
13.2.2 Forecast Trend (2024-2032)
13.3 United Arab Emirates
13.3.1 Historical Trend (2017-2023)
13.3.2 Forecast Trend (2024-2032)
13.4 Nigeria
13.4.1 Historical Trend (2017-2023)
13.4.2 Forecast Trend (2024-2032)
13.5 South Africa
13.5.1 Historical Trend (2017-2023)
13.5.2 Forecast Trend (2024-2032)
13.6 Others
14 Global Endometriosis Treatment Market Dynamics
14.1 Market Drivers and Constraints
14.2 SWOT Analysis
14.3 Porter’s Five Forces Model
14.4 Key Demand Indicators
14.5 Key Price Indicators
14.6 Industry Events, Initiatives, and Trends
14.7 Value Chain Analysis
15 Supplier Landscape
15.1 Abbott
15.1.1 Company Overview
15.1.2 Product Portfolio
15.1.3 Demographic Reach and Achievements
15.1.4 Mergers and Acquisitions
15.1.5 Certifications
15.2 AbbVie Inc.
15.2.1 Company Overview
15.2.2 Product Portfolio
15.2.3 Demographic Reach and Achievements
15.2.4 Mergers and Acquisitions
15.2.5 Certifications
15.3 Bayer AG
15.3.1 Company Overview
15.3.2 Product Portfolio
15.3.3 Demographic Reach and Achievements
15.3.4 Mergers and Acquisitions
15.3.5 Certifications
15.4 Pfizer Inc.
15.4.1 Company Overview
15.4.2 Product Portfolio
15.4.3 Demographic Reach and Achievements
15.4.4 Mergers and Acquisitions
15.4.5 Certifications
15.5 Ipsen Pharma
15.5.1 Company Overview
15.5.2 Product Portfolio
15.5.3 Demographic Reach and Achievements
15.5.4 Mergers and Acquisitions
15.5.5 Certifications
15.6 Evotec SE
15.6.1 Company Overview
15.6.2 Product Portfolio
15.6.3 Demographic Reach and Achievements
15.6.4 Mergers and Acquisitions
15.6.5 Certifications
15.7 Myovant Sciences GmbH
15.7.1 Company Overview
15.7.2 Product Portfolio
15.7.3 Demographic Reach and Achievements
15.7.4 Mergers and Acquisitions
15.7.5 Certifications
15.8 Philogen S.p.A.
15.8.1 Company Overview
15.8.2 Product Portfolio
15.8.3 Demographic Reach and Achievements
15.8.4 Mergers and Acquisitions
15.8.5 Certifications
15.9 Astellas Pharma Inc.
15.9.1 Company Overview
15.9.2 Product Portfolio
15.9.3 Demographic Reach and Achievements
15.9.4 Mergers and Acquisitions
15.9.5 Certifications
15.10 Orphagen Pharmaceuticals
15.10.1 Company Overview
15.10.2 Product Portfolio
15.10.3 Demographic Reach and Achievements
15.10.4 Mergers and Acquisitions
15.10.5 Certifications
16 Global Endometriosis Treatment Market- Drugs Distribution Model (Additional Insight)
16.1 Overview
16.2 Potential Distributors
16.3 Key Parameters for Distribution Partner Assessment
17 Payment Methods (Additional Insight)
17.1 Government Funded
17.2 Private Insurance
17.3 Out-of-Pocket
*Additional insights provided are customizable as per client requirements.
The endometriosis market attained a value of nearly USD 1.55 billion in 2023.
The market is projected to grow at a CAGR of 7.7% during the forecast period of 2024-2032.
The market is estimated to witness a healthy growth in the forecast period of 2024-2032 to reach USD 3.02 billion by 2032.
The growth of the market is driven by factors like rising cases of endometriosis due to the rising issues in women of reproductive age and the rising awareness about the disease.
The rapid advancements and developments in the market acts as a key trend for the market.
The indications of the disease include superficial peritoneal lesion, endometrioma, and deeply infiltrating endometriosis, among others.
The diagnostic methods include ultrasound, pelvic examination, laparoscopy, and magnetic resonance imaging, among others.
The treatment methods include hormonal therapy and pain management, among others.
The drugs include oral contraceptives, progestins, NSAIDs, and GnRH analogues, among others.
The distribution channels include hospital pharmacies, retail pharmacies, and online pharmacies.
The major regions in the market are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific, with North America accounting for the largest share of the market.
The key players in the market include Abbott, AbbVie Inc., Bayer AG, Pfizer Inc., Ipsen Pharma, Evotec SE, Myovant Sciences GmbH, Philogen S.p.A., Astellas Pharma Inc., and Orphagen Pharmaceuticals, among others.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.